Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock — Stella

Recruiting

Back to Septic Shock trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Italy

Azienda Unità Sanitaria Locale, Bologna

Key details

Phase

Post-approval study

Sponsor

Azienda Usl di Bologna

Enrollment target

~264 participants

Started

May 2024

Primary completion

May 2026

Age range

18 Years – 80 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov